{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:12:56Z","timestamp":1793812376584,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60939-3","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:07:56Z","timestamp":1783480076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding the landscape of hereditary breast and ovarian cancer testing in Brazil"],"prefix":"10.1038","volume":"16","author":[{"given":"Daniele","family":"Paix\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneliese Lopes","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Figueiredo","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betania","family":"Loures","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Emilia Prior","family":"Carnavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha Ribeiro","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzane","family":"De Andrade Barboza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Mendes","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Dias","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais Rodrigues","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Rezende Bandeira","family":"de Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Gon\u00e7alves Pereira","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Thamires","family":"Batista Do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M\u00f4naco","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Napolitano e Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner Ant\u00f4nio","family":"da Rosa Baratela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e1litta Hetamaro Ayala","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"60939_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature09796","volume":"470","author":"ER Mardis","year":"2011","unstructured":"Mardis, E. R. A decade\u2019s perspective on DNA sequencing technology. Nature 470, 198\u2013203 (2011).","journal-title":"Nature"},{"key":"60939_CR2","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/gim.2014.40","volume":"16","author":"H LaDuca","year":"2014","unstructured":"LaDuca, H. et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet. Med. 16, 830\u2013837 (2014).","journal-title":"Genet. Med."},{"key":"60939_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-10-1503-8_1","volume":"939","author":"S Teng","year":"2016","unstructured":"Teng, S. NGS for sequence variants. Adv. Exp. Med. Biol. 939, 1\u201320 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"key":"60939_CR4","doi-asserted-by":"crossref","unstructured":"Strachan, T. & Lucassen, A. Genetics and Genomics in Medicine (Taylor & Francis Group, 2023).","DOI":"10.1201\/9781003044406"},{"key":"60939_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cancergencyto.2005.07.005","volume":"168","author":"S Preisler-Adams","year":"2006","unstructured":"Preisler-Adams, S. et al. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet. Cytogenet. 168, 44\u201349 (2006).","journal-title":"Cancer Genet. Cytogenet."},{"key":"60939_CR6","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1200\/JCO.2006.06.9443","volume":"25","author":"PM Machado","year":"2007","unstructured":"Machado, P. M. et al. Screening for a BRCA2 rearrangement in high-risk breast\/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J. Clin. Oncol. 25, 2027\u20132034 (2007).","journal-title":"J. Clin. Oncol."},{"key":"60939_CR7","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1200\/JCO.24.00662","volume":"42","author":"N Tung","year":"2024","unstructured":"Tung, N. et al. Selection of germline genetic testing panels in patients with cancer: ASCO guideline. J. Clin. Oncol. 42, 2599\u20132615 (2024).","journal-title":"J. Clin. Oncol."},{"key":"60939_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrg1767","volume":"7","author":"L Feuk","year":"2006","unstructured":"Feuk, L., Carson, A. R. & Scherer, S. W. Structural variation in the human genome. Nat. Rev. Genet. 7, 85\u201397 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"60939_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41436-018-0033-5","volume":"21","author":"R Truty","year":"2019","unstructured":"Truty, R. et al. Prevalence and properties of intragenic copy-number variation in Mendelian disease genes. Genet. Med. 21, 114\u2013123 (2019).","journal-title":"Genet. Med."},{"key":"60939_CR10","doi-asserted-by":"publisher","first-page":"976959","DOI":"10.3389\/fonc.2022.976959","volume":"12","author":"D Paix\u00e3o","year":"2022","unstructured":"Paix\u00e3o, D. et al. Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. Front. Oncol. 12, 976959 (2022).","journal-title":"Front. Oncol."},{"key":"60939_CR11","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1038\/s41598-022-07383-1","volume":"12","author":"RSC Guindalini","year":"2022","unstructured":"Guindalini, R. S. C. et al. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. Sci. Rep. 12, 4190 (2022).","journal-title":"Sci. Rep."},{"key":"60939_CR12","doi-asserted-by":"publisher","first-page":"e0247363","DOI":"10.1371\/journal.pone.0247363","volume":"16","author":"RL Sandoval","year":"2021","unstructured":"Sandoval, R. L. et al. Germline molecular data in hereditary breast cancer in Brazil: lessons from a large single-center analysis. PLoS One. 16, e0247363 (2021).","journal-title":"PLoS One"},{"key":"60939_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10549-018-4938-0","volume":"172","author":"AR de Souza Timoteo","year":"2018","unstructured":"de Souza Timoteo, A. R. et al. A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer. Breast Cancer Res. Treat. 172, 637\u2013646 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"60939_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"60939_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.18632\/oncotarget.26501","volume":"10","author":"TP Slavin","year":"2019","unstructured":"Slavin, T. P., Manjarrez, S., Pritchard, C. C., Gray, S. & Weitzel, J. N. The effects of genomic germline variant reclassification on clinical cancer care. Oncotarget 10, 417\u2013423 (2019).","journal-title":"Oncotarget"},{"key":"60939_CR16","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Genetic\/Familial High-Risk Assessment (Breast, Ovarian, Pancreatic and Prostate) \u2014 Version 3.2026 (NCCN, 2026)."},{"key":"60939_CR17","unstructured":"Durkie, M. et al. ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2024 (Association for Clinical Genomic Science, 2024)."},{"key":"60939_CR18","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm, H. L. et al. ClinGen\u2014the clinical genome resource. N Engl. J. Med. 372, 2235\u20132242 (2015).","journal-title":"N Engl. J. Med."},{"key":"60939_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jamaoncol.2015.4771","volume":"2","author":"J Whitworth","year":"2016","unstructured":"Whitworth, J. et al. Multilocus inherited neoplasia alleles syndrome: a case series and review. JAMA Oncol. 2, 373\u2013379 (2016).","journal-title":"JAMA Oncol."},{"key":"60939_CR20","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/tbj.13971","volume":"26","author":"S Reid","year":"2020","unstructured":"Reid, S. & Pal, T. Update on multigene panel testing and communication of genetic test results. Breast J. 26, 1513\u20131519 (2020).","journal-title":"Breast J."},{"key":"60939_CR21","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","volume":"35","author":"CP Childers","year":"2017","unstructured":"Childers, C. P., Childers, K. K., Maggard-Gibbons, M. & Macinko, J. National estimates of genetic testing in women with a history of breast or ovarian cancer. J. Clin. Oncol. 35, 3800\u20133806 (2017).","journal-title":"J. Clin. Oncol."},{"key":"60939_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch, P. D. et al. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J. Clin. Oncol. 37, 453\u2013460 (2019).","journal-title":"J. Clin. Oncol."},{"key":"60939_CR23","doi-asserted-by":"crossref","unstructured":"Fecteau, H. & Pal, T. Clinical considerations in the conduct of cancer next-generation sequencing testing and genetic counselling. In Next Generation Sequencing in Cancer Research, Volume 2 (eds. Wu, W. & Choudhry, H.) (Springer, 2015).","DOI":"10.1007\/978-3-319-15811-2_6"},{"key":"60939_CR24","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","volume":"20","author":"KP Pennington","year":"2014","unstructured":"Pennington, K. P. et al. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin. Cancer Res. 20, 764\u2013775 (2014).","journal-title":"Clin. Cancer Res."},{"key":"60939_CR25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/JCO.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian, A. W. et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J. Clin. Oncol. 37, 1305\u20131315 (2019).","journal-title":"J. Clin. Oncol."},{"key":"60939_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12885-018-5235-3","volume":"19","author":"DP Cotrim","year":"2019","unstructured":"Cotrim, D. P. et al. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in nonselected ovarian carcinoma patients in Brazil. BMC Cancer. 19, 4 (2019).","journal-title":"BMC Cancer"},{"key":"60939_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s12885-024-12246-1","volume":"24","author":"C de Oliveira Ferreira","year":"2024","unstructured":"de Oliveira Ferreira, C. & Carneiro, V. C. G. Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System. BMC Cancer. 24, 499 (2024).","journal-title":"BMC Cancer"},{"key":"60939_CR28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1200\/JCO.18.01512","volume":"37","author":"T Abe","year":"2019","unstructured":"Abe, T. et al. Deleterious germline mutations are a risk factor for neoplastic progression among high-risk individuals undergoing pancreatic surveillance. J. Clin. Oncol. 37, 1070\u20131080 (2019).","journal-title":"J. Clin. Oncol."},{"key":"60939_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/jcm14020367","volume":"14","author":"C Blanco Abad","year":"2025","unstructured":"Blanco Abad, C. et al. Hereditary pancreatic cancer: advances in genetic testing, early detection strategies, and personalized management. J. Clin. Med. 14, 367 (2025).","journal-title":"J. Clin. Med."},{"key":"60939_CR30","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3390\/ijms19041255","volume":"19","author":"SH Tan","year":"2018","unstructured":"Tan, S. H., Petrovics, G. & Srivastava, S. Prostate cancer genomics: recent advances and the prevailing underrepresentation from racial and ethnic minorities. Int. J. Mol. Sci. 19, 1255 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"60939_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12920-019-0652-y","volume":"13","author":"E da Costa","year":"2020","unstructured":"da Costa, E. et al. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC Med. Genomics. 13, 21 (2020).","journal-title":"BMC Med. Genomics"},{"key":"60939_CR32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41431-022-01098-7","volume":"30","author":"JM de Oliveira","year":"2022","unstructured":"de Oliveira, J. M. et al. The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients. Eur. J. Hum. Genet. 30, 818\u2013823 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"60939_CR33","doi-asserted-by":"publisher","first-page":"698595","DOI":"10.3389\/fgene.2021.698595","volume":"12","author":"P Bhai","year":"2021","unstructured":"Bhai, P. et al. Analysis of sequence and copy number variants in canadian patient cohort with familial cancer syndromes using a unique next generation sequencing based approach. Front. Genet. 12, 698595 (2021).","journal-title":"Front. Genet."},{"key":"60939_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung, N. et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121, 25\u201333 (2015).","journal-title":"Cancer"},{"key":"60939_CR35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.21873\/cgp.20463","volume":"21","author":"N Tsoulos","year":"2024","unstructured":"Tsoulos, N. et al. The clinical and genetic landscape of hereditary cancer: experience from a single clinical diagnostic laboratory. Cancer Genomics Proteom. 21, 448\u2013463 (2024).","journal-title":"Cancer Genomics Proteom."},{"key":"60939_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10549-008-0088-0","volume":"115","author":"TV Hansen","year":"2008","unstructured":"Hansen, T. V. et al. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Breast Cancer Res. Treat. 115, 315\u2013323 (2008).","journal-title":"Breast Cancer Res. Treat."},{"key":"60939_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1399-0004.2010.01463.x","volume":"78","author":"M Rodr\u00edguez","year":"2010","unstructured":"Rodr\u00edguez, M., Torres, A., Borr\u00e0s, J., Salvat, M. & Gum\u00e0, J. Large genomic rearrangements in mutation-negative BRCA families: a population-based study. Clin. Genet. 78, 405\u2013407 (2010).","journal-title":"Clin. Genet."},{"key":"60939_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1590\/1678-4685-gmb-2014-0350","volume":"39","author":"IP Ewald","year":"2016","unstructured":"Ewald, I. P. et al. BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome. Genet. Mol. Biol. 39, 223\u2013231 (2016).","journal-title":"Genet. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60939-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60939-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60939-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:01:49Z","timestamp":1791457309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60939-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60939"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60939-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors are employees (received salary and other bonuses) of Genesis Genomics.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"31351"}}